If you need to quickly assess whether a patient might have cannabis use disorder, ask them how often they’ve used cannabis in the past year. At least, that is the suggestion put forward in new research published this week.
Writing in the Conversation, Benjamin Land, a research associate professor of pharmacology at the University of Washington, explains how cannabis could be used as an opioid substitute.
The certificate was awarded on October 20 to Viridis Laboratories, a cannabis lab in Michigan.
The state’s Office of Cannabis Management has removed the pass/fail limits associated with the total yeast and mold counts for cannabis flower and pre-rolls.
Chris Hudalla, president and chief scientific officer at ProVerde Laboratories, explores the legality and implications of novel synthetic cannabinoids.
Regulators in Colorado have found “potentially unsafe” levels of Aspergillus mold on batches of medical cannabis flower.
Genetec's Scott Thomas outlines the three security factors every entrepreneur should consider before opening their cannabis production facility.
The researchers argue that the medical establishment should find a new approach to determining transplant candidacy for cannabis users.
Analytical Cannabis recently caught up with the minds behind Cannatrol to learn more about cannabis drying and the company's innovative approach to curing.